Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs


Por: Sánchez-Recillas A., Navarrete-Vázquez G., Hidalgo-Figueroa S., Rios M.Y., Ibarra-Barajas M., Estrada-Soto S.

Publicada: 1 abr 2014
Resumen:
Asthma is a chronic inflammatory disorder that causes contraction in the smooth muscle of the airway and blocking of airflow. Reversal the contractile process is a strategy for the search of new drugs that could be used for the treatment of asthma. This work reports the semisynthesis, ex vivo relaxing evaluation and SAR studies of a series of 18 coumarins. The results pointed that the ether derivatives 1-3, 7-9 and 13-15 showed the best activity (E max = 100%), where compound 2 (42 µM) was the most potent, being 4-times more active than theophylline (positive control). The ether homologation (methyl, ethyl and propyl) in position 7 or positions 6 and 7 of coumarins lead to relaxing effect, meanwhile formation of esters generated less active compounds than ethers. The SAR analysis showed that it is necessary the presence of two small ether groups and the methyl group at position 4 (site 3) encourage biological activity through soft hydrophobic changes in the molecule, without drastically affecting the cLogP.© 2014 Elsevier Masson SAS. All rights reserved.

Filiaciones:
Sánchez-Recillas A.:
 Laboratorio de Farmacognosia y Química de Productos Naturales, Facultad de Farmacia, Universidad Autónoma Del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa, 62209 Cuernavaca, Morelos, Mexico

Navarrete-Vázquez G.:
 Laboratorio de Química Farmacéutica, Facultad de Farmacia, Universidad Autónoma Del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa, 62209 Cuernavaca, Morelos, Mexico

Hidalgo-Figueroa S.:
 Laboratorio de Química Farmacéutica, Facultad de Farmacia, Universidad Autónoma Del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa, 62209 Cuernavaca, Morelos, Mexico

Rios M.Y.:
 Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa, 62209 Cuernavaca, Morelos, Mexico

Ibarra-Barajas M.:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Tlalnepantla 54090, Estado De Mexic, Mexico

Estrada-Soto S.:
 Laboratorio de Farmacognosia y Química de Productos Naturales, Facultad de Farmacia, Universidad Autónoma Del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa, 62209 Cuernavaca, Morelos, Mexico
ISSN: 02235234
Editorial
Elsevier Masson SAS, 23 RUE LINOIS, 75724 PARIS, FRANCE, Francia
Tipo de documento: Article
Volumen: 77 Número:
Páginas: 400-408
WOS Id: 000335874800043
ID de PubMed: 24681028